Montserrat Estruch Alrich

Montserrat Estruch Alrich

Assistant Professor

Member of:

    ORCID: 0000-0002-7162-4158

    Publication year:
    All
    1 - 8 out of 8Page size: 10
    1. 2023
    2. Published

      Presence of Ceramidase Activity in Electronegative LDL

      Puig, N., Rives, J., Estruch Alrich, Montserrat, Aguilera-Simon, A., Rotllan, N., Camacho, M., Colomé, N., Canals, F., Sánchez-Quesada, J. L. & Benitez, S., 2023, In: International Journal of Molecular Sciences. 24, 13 p., 165.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. 2022
    4. Published

      Inhibition of oxidized nucleotide sanitation by TH1579 and conventional chemotherapy cooperatively enhance oxidative DNA-damage and survival in AML

      Centio, A., Estruch Alrich, Montserrat, Reckzeh, K., Sanjiv, K., Vittori, Camilla, Engelhard, Sophia Manon Charlotte, Warpman Berglund, U., Helleday, T. & Theilgaard-Mønch, Kim, 2022, In: Molecular Cancer Therapeutics. p. 703-714

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event

      Reckzeh, K., Estruch Alrich, Montserrat, Ali, M., Helbo, A. S., Mosbech, A., Won, K. J., Rücker, F., Döhner, K. & Theilgaard-Mønch, Kim, 2022, In: British Journal of Haematology. 197, 2, p. 201-206

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. 2021
    7. Published

      MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia

      Sanjiv, K., Calderón-Montaño, J. M., Pham, T. M., Erkers, T., Tsuber, V., Almlöf, I., Höglund, A., Heshmati, Y., Seashore-Ludlow, B., Nagesh Danda, A., Gad, H., Wiita, E., Göktürk, C., Rasti, A., Friedrich, S., Centio, A., Estruch, M., Våtsveen, T. K., Struyf, N., Visnes, T. & 12 others, Scobie, M., Koolmeister, T., Henriksson, M., Wallner, O., Sandvall, T., Lehmann, S., Theilgaard-Mønch, Kim, Garnett, M. J., Östling, P., Walfridsson, J., Helleday, T. & Warpman Berglund, U., 2021, In: Cancer Research. 81, 22, p. 5733-5744 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Published

      Novel Combination Treatments for AML

      Estruch Alrich, Montserrat, Vittori, Camilla, Muñoz-Montesinos, T., Reckzeh, K. & Theilgaard-Mønch, Kim, 2021, In: Journal of Cellular Immunology. 3, 4, 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy

      Estruch Alrich, Montserrat, Reckzeh, K., Vittori, Camilla, Centio, A., Ali, M., Engelhard, Sophia Manon Charlotte, Zhao, L., Won, K. J., Liu, P., Porse, Bo Torben & Theilgaard-Mønch, Kim, 2021, In: Leukemia. 35, p. 2030-2042

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance

      Estruch Alrich, Montserrat, Vittori, Camilla, Montesinos, T. M., Reckzeh, K. & Theilgaard-Mønch, Kim, 2021, In: Cancer Drug Resistance. 4, p. 984-995

      Research output: Contribution to journal › Journal article › Research › peer-review

    11. 2018
    12. Published

      Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin

      Reckzeh, K., Kizilkaya, Hüsün Sheyma, Helbo, A. S., Estruch Alrich, Montserrat, Deslauriers, A. G., Grover, A., Rapin, N., Asmar, F., Grønbæk, Kirsten, Porse, Bo Torben, Borregaard, N., Vestweber, D., Nerlov, C. & Theilgaard-Mønch, Kim, 2018, In: Blood advances. 2, 13, p. 1628-1632 5 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 156727730